|
Market Closed -
Bombay S.E.
18:28:06 10/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,840.80 INR | -1.57% |
|
-3.59% | +14.97% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 481B 5.03B 4.33B 4.08B 3.72B 6.96B 7.02B 48.64B 18.72B 244B 18.9B 18.49B 775B | P/E 2027 * |
41.3x | P/E 2028 * | 35.9x |
|---|---|---|---|---|---|
| Enterprise Value | 481B 5.03B 4.33B 4.08B 3.72B 6.96B 7.02B 48.64B 18.72B 244B 18.9B 18.49B 775B | EV / Sales 2027 * |
11.3x | EV / Sales 2028 * | 10.2x |
| Free-Float |
-
| Yield 2027 * |
1.04% | Yield 2028 * | 1.04% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript : GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -1.57% | ||
| 1 week | -3.59% | ||
| Current month | -6.95% | ||
| 1 month | +9.55% | ||
| 3 months | +29.45% | ||
| 6 months | +12.65% | ||
| Current year | +14.97% |
| 1 week | 2,836.25 |  | 3,074 |
| 1 month | 2,577.9 | | 3,121.1 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.57% | -3.59% | +0.80% | +94.38% | 5.14B | |
| -0.11% | -3.16% | +48.82% | +88.56% | 1,002B | |
| -0.27% | -4.34% | +51.52% | +63.75% | 644B | |
| +1.63% | -2.00% | +20.49% | +71.10% | 443B | |
| -0.63% | -1.06% | +28.11% | +34.59% | 343B | |
| +0.43% | -14.61% | +9.88% | +27.26% | 262B | |
| +0.93% | -1.82% | -1.82% | +8.41% | 245B | |
| -2.25% | -13.88% | +37.33% | +46.14% | 212B | |
| -0.90% | -5.09% | -15.47% | -57.75% | 199B | |
| -0.58% | -4.24% | +25.65% | +87.97% | 181B | |
| Average | +0.01% | -4.70% | +20.53% | +46.44% | 353.48B | |
| Weighted average by Cap. | +0.40% | -4.24% | +31.80% | +55.74% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.57B 445M 383M 361M 329M 615M 621M 4.3B 1.66B 21.59B 1.67B 1.64B 68.58B | 47.24B 494M 425M 401M 365M 683M 689M 4.78B 1.84B 23.96B 1.86B 1.81B 76.11B |
| Net income | 11.65B 122M 105M 98.91M 90.11M 168M 170M 1.18B 453M 5.91B 458M 448M 18.78B | 13.42B 140M 121M 114M 104M 194M 196M 1.36B 522M 6.81B 527M 515M 21.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | ₹2,840.80 | -1.57% | 2,065 |
| 09/09/26 | ₹2,886.15 | -1.45% | 3,416 |
| 08/09/26 | ₹2,928.70 | -0.96% | 1,897 |
| 07/09/26 | ₹2,956.95 | -0.06% | 24,980 |
| 04/09/26 | ₹2,958.60 | +0.79% | 1,734 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
